IRADIMED CORPORATION announced its participation in the 38th Annual Roth Conference on March 22 and 24, 2026, at the Ritz-Carlton in Laguna Niguel, CA. CEO Roger Susi and CFO Jack Glenn will host one-on-one meetings with investors. The company is a leader in MRI-compatible medical devices, including its patented MRidium® IV infusion pump system and 3880 patient vital signs monitoring system.

Iradimed Corporation's stock surged 9.26% after reporting its 18th consecutive quarter of record revenue at $22.7 million (up 17% YoY) and beating adjusted net income estimates at $0.54 per share versus $0.48 expected. The medical device maker, which specializes in MRI-compatible infusion pump systems, launched a new product and raised its quarterly dividend from $0.17 to $0.20 per share. The company provided 2026 guidance of $91-96 million in revenue and $2.06-2.21 adjusted net income per share.

Baker Hughes, an energy technology company, has two segments: Oilfield Services & Equipment (OFSE) and Industrial & Energy Technology (IET). The report provides insights into the company's digital transformation strategies, innovation programs, and technology initiatives.

The global well intervention market is projected to reach USD 12.14 Billion by 2031, driven by new oilfield developments, rising energy demand, and the need to maintain the integrity of aging oil and gas wells. The market is expected to grow at a CAGR of 4.8% during the forecast period.

Trading to commence effective on the market open June 14, 2024 Trading to commence effective on the market open June 14, 2024

WINTER SPRINGS, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 first quarter financial results before the market opens on Thursday, May 2, 2024. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.

IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference

WINTER SPRINGS, Fla., Feb. 08, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) announced today its financial results for the three months and year ended December 31, 2023. The Company is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system, and non-magnetic patient vital signs monitoring systems that are designed for use during MRI procedures.

WINTER SPRINGS, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 fourth quarter financial results before the market opens on Thursday, February 8, 2024. Iradimed management will host a conference call the same day beginning at 9:00 a.m. Eastern Time to discuss those results and to answer questions.

IRADIMED CORPORATION Announces Participation in 42nd Annual J.P. Morgan Healthcare Conference

Acadia Healthcare (ACHC) conducts a ribbon-cutting ceremony for its Indio-based acute care facility, which aims to cater to the dire need for high-quality behavioral healthcare services in the region.

WINTER SPRINGS, Fla., Dec. 12, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) announced today that its Board of Directors approved a special cash dividend of $0.48 per share and the initiation of a regular quarterly dividend on the Company's outstanding common stock. The regular quarterly dividend is $0.15 per share. The special cash dividend and the quarterly dividend are payable on January 12, 2024, to shareholders of record at the close of business on December 22, 2023.